# Delivery Order #SPE2D326F199W

Pfizer Delivery Order for Injectable Tranexamic Acid

**Buyer:** Defense Logistics Agency

**Award Amount:** $179.68
**Ceiling:** $179.68

**Awarded:** June 17, 2026
**Period of Performance:** Jun 17, 2026 - Jun 18, 2026

**Identifier:** SPE2D326F199W
**NAICS:** 325412

The Defense Logistics Agency issued Pfizer Inc. a delivery order under an existing indefinite-delivery contract for Cyklokapron (tranexamic acid), an injectable medicine supplied in 1,000 mg/10 mL vials. Pfizer develops and manufactures pharmaceutical products, and this order supports the agency’s procurement of medicines for federal use. The scope shown is the supply of the specified injectable medication; no broader services or additional deliverables are identified. The parent contract is a long-term pharmaceutical supply vehicle that runs through 2030. The order covers a brief delivery period in June 2026. The record does not identify whether this individual order was competed or sole-source, nor does it provide an associated solicitation, acquisition program, subcontractors, or prior related orders.

### Description

4572166140!CYKLOKAPRON 1,000 MG/10 ML VL 10ML

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2D326F199W_9700_SPE2D020D0014_9700)
